SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
SCHEDULE 13G
|
(Rule 13d-102)
|
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
|
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
|
PURSUANT TO RULE 13d-2(b)
|
(Amendment No. )1
|
Aldeyra Therapeutics, Inc.
|
(Name of Issuer)
|
Common Stock, $.001 par value
|
(Title of Class of Securities)
|
01438T106
|
(CUSIP Number)
|
December 31, 2014
|
(Date of Event Which Requires Filing of this Statement)
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson
EIN: 22-1024240
|
|||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5.
|
SOLE VOTING POWER -0-
|
|
6.
|
SHARED VOTING POWER 1,750,292*
|
|||
7.
|
SOLE DISPOSITIVE POWER -0-
|
|||
8.
|
SHARED DISPOSITIVE POWER 1,750,292*
|
|||
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON 1,750,292*
|
|||
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
[ ]
|
||
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)31.4% **
|
|||
12.
|
TYPE OF REPORTING PERSON CO
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson Innovation - JJDC, Inc.***
EIN: 22-2007137
|
|||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5.
|
SOLE VOTING POWER -0-
|
|
6.
|
SHARED VOTING POWER 1,750,292*
|
|||
7.
|
SOLE DISPOSITIVE POWER -0-
|
|||
8.
|
SHARED DISPOSITIVE POWER 1,750,292*
|
|||
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON 1,750,292*
|
|||
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
[ ]
|
||
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)31.4% **
|
|||
12.
|
TYPE OF REPORTING PERSON CO
|
ITEM 1(a)
|
NAME OF ISSUER:
|
||
Aldeyra Therapeutics, Inc.
|
|||
ITEM 1(b)
|
ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
|
||
131 Hartwell Avenue, Suite 320
Lexington, MA 02421
|
|||
ITEM 2(a)
|
NAME OF PERSON FILING:
|
||
This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation (“JJDC”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC.
|
|||
ITEM 2(b)
|
ADDRESS OF PRINCIPAL BUSINESS OFFICE:
|
||
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
|
|||
ITEM 2(c)
|
CITIZENSHIP:
|
||
J&J: New Jersey
|
|||
JJDC: New Jersey
|
|||
ITEM 2(d)
|
TITLE OF CLASS OF SECURITIES:
|
||
Common Stock, $.001 par value per share
|
|||
ITEM 2(e)
|
CUSIP NUMBER:
|
||
01438T106
|
|||
ITEM 3
|
STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B) OR (C):
|
||
Not applicable.
|
|||
ITEM 4
|
OWNERSHIP:
(a) through (c)
The information requested hereunder is set forth in Items 5 through 9 and 11 of the cover pages to this Schedule 13G.
|
||
ITEM 5
|
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
|
||
Not applicable.
|
ITEM 6
|
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
|
Not applicable.
|
|
ITEM 7
|
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:
|
Not applicable.
|
|
ITEM 8
|
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
|
Not applicable.
|
|
ITEM 9
|
NOTICE OF DISSOLUTION OF GROUP:
|
Not applicable.
|
|
ITEM 10
|
CERTIFICATION:
|
Not applicable.
|
JOHNSON & JOHNSON
|
||
By:
|
/s/ Douglas Chia
|
|
Name:
|
Douglas Chia
|
|
Title:
|
Secretary
|
|
JOHNSON & JOHNSON INNOVATION - JJDC, INC.
|
||
By:
|
/s/ Steven M. Rosenberg
|
|
Name:
|
Steven M. Rosenberg
|
|
Title:
|
Secretary
|